RxDoctor Payments Data

Michael Hannon, MD

Cardiovascular Disease · Rochester, NYNPI 1043607195

Payments from drug & device makers

$4,679in general payments, 2019–2025

Across 33 payments — averaging $141.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Medtronic$2K
  • AstraZeneca$217
  • Teleflex LLC$144
  • E.r. Squibb & Sons, L.L.C.$125
  • Pfizer$124
  • plus $232 from 4 others

What the payments were for

  • Travel & lodging$2,11045%
  • Food & beverage$2,27549%
  • Education$2946%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,679 in reported general payments places this provider in the 65th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York

Medicare billing

Part B allowed, 2024
$29,079
Medicare patients
46
Services billed
195

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Rochester

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →